Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Breast (Edinburgh, Scotland)|June 30, 2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51DR Graffeo, H Q Rana, F Conforti, et al.
ESMO Open|September 6, 2025
Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challengeR Gerosa, G Gentile, L Arecco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patientsM Lambertini, O Goldrat, A R Ferreira, et al.
ESMO Open|July 6, 2023
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysisC Molinelli, F Jacobs, E Agostinetto, et al.
Breast (Edinburgh, Scotland)|April 1, 2017
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysisF Poggio, M Ceppi, M Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesM Lambertini, M Ceppi, F Poggio, et al.
Journal of Assisted Reproduction and Genetics|December 21, 2022
Pediatric oncofertility care in limited versus optimum resource settings: results from 39 surveyed centers in Repro-Can-OPEN Study Part I & IIM Salama, L Nahata, Y Jayasinghe, et al.
Human Reproduction (Oxford, England)|December 8, 2020
Impact of ARTs on oncological outcomes in young breast cancer survivorsM Condorelli, M De Vos, S Lie Fong, et al.
Cancer Investigation|April 25, 2022
Breast Cancer Patients' Experience and Wishes Regarding Communication on Sexual Health: The BEROSE StudyM Aupomerol, D Chaltiel, P Pautier, et al.
ESMO Open|January 7, 2026
Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trialsR Borea, E Blondeaux, L Carmisciano, et al.
Pageof 7